Orbimed Advisors LLC Century Therapeutics, Inc. Transaction History

Orbimed Advisors LLC

  • $4.24 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$11.62 - $15.92 $3.57 Million - $4.89 Million
-307,047 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$13.93 - $23.62 $1.39 Million - $2.36 Million
-100,000 Reduced 24.57%
307,047 $4.87 Million
Q2 2021

Aug 16, 2021
BUY
$22.45 - $29.34 $9.14 Million - $11.9 Million
407,047 New
407,047 $11.9 Million

Others Institutions Holding IPSC

# of Institutions
67
Shares Held
36.9M
Call Options Held
8.7K
Put Options Held
10.2K
View Full List

About Century Therapeutics, Inc.

IPSC Quotes by TradingView
  • Ticker IPSC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,881,800
  • Market Cap $68.9M
  • Description
  • Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...
More about IPSC
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email